Immunotherapy in SCLC: Challenges and Opportunities of Rapidly Evolving Treatments

Download All
Get up to date on optimal use of immunotherapy in the care of your patients with small-cell lung cancer with an interactive on-demand Webcast and downloadable slides from a live Webinar, along with a podcast featuring expert answers to frequently asked questions.
Anna F. Farago, MD, PhD
Taofeek K. Owonikoko, MD, PhD

Podcast

In this podcast episode, listen to lung cancer experts Anna F. Farago, MD, PhD, and Taofeek K. Owonikoko, MD, PhD, answer audience questions from a live CCO Webinar on the topic of immunotherapy in SCLC.

Anna F. Farago, MD, PhD Taofeek K. Owonikoko, MD, PhD Released: August 27, 2020

On-Demand Webcast

In this interactive, on-demand Webcast, lung cancer experts review the evolving role of immunotherapy in the treatment of small-cell lung cancer, including patient case discussions and discussion of new data from the 2020 ASCO Virtual Scientific Meeting.

Downloadable Slidesets

Download this short summary slideset of key takeaways from a live CCO Webinar focused on key data informing the optimal use of immune checkpoint inhibition for the treatment of advanced SCLC.

Anna F. Farago, MD, PhD Taofeek K. Owonikoko, MD, PhD Released: July 15, 2020

Download this slideset to review the latest data informing optimal use of frontline immune checkpoint inhibition for the treatment of advanced SCLC, including an update on the role of biomarkers.

Anna F. Farago, MD, PhD Taofeek K. Owonikoko, MD, PhD Released: July 9, 2020

Download this slideset to review the latest data informing optimal use of immune checkpoint inhibition for the treatment of pretreated SCLC, including recommendations for immune-related adverse events.

Anna F. Farago, MD, PhD Taofeek K. Owonikoko, MD, PhD Released: July 9, 2020
Provided by Clinical Care Options, LLC.

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Genentech, a member of the Roche Group
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue